Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Assisted real estate developer in the assemblage and acquisition of a downtown Raleigh site for future urban high-rise mixed use project
Assisted real estate developer in the acquisition of a site in downtown Raleigh that will one day be home to an urban mixed use public-private more
China expansion for one of the world's leading providers of lighting fixtures
Represented one of the world's leading providers of lighting fixtures and related products and services in structuring its expanding operations in more
Project counsel for international contractor in major road tunnel construction
Represents an international contractor in an ongoing construction of a major road tunnel under Stockholm City, a part of the new highway bypass in more
Electronic health records for a national beverage manufacturer
Assisted a national beverage manufacturer in designing electronic health records for its employee group health plan. more